Online Database of Chemicals from Around the World

2-(2,6-Dioxopiperidin-3-yl)-4-fluoro-2,3-dihydro-1H-isoindole-1,3-dione
[CAS# 835616-60-9]

Top Active Suppliers
Shanghai Worldyang Chemical Co., Ltd. China Inquire  
+86 13651600618
+86 (21) 5679-5779
sales7777@worldyachem.com
QQ chat
WeChat: 13651600618
WhatsApp: +86 13651600618
Chemical manufacturer since 2012
chemBlink premium supplier since 2023
Identification
Classification Organic raw materials >> Heterocyclic compound >> Indoles
Name 2-(2,6-Dioxopiperidin-3-yl)-4-fluoro-2,3-dihydro-1H-isoindole-1,3-dione
Synonyms 2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindolin-1,3-dione; 2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione; 4-Fluoro-thalidomide
Molecular Structure CAS # 835616-60-9, 2-(2,6-Dioxopiperidin-3-yl)-4-fluoro-2,3-dihydro-1H-isoindole-1,3-dione, 2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindolin-1,3-dione, 2-(2,6-Dioxopiperidin-3-yl)-4-fluoroisoindoline-1,3-dione, 4-Fluoro-thalidomide
Molecular Formula C13H9FN2O4
Molecular Weight 276.22
CAS Registry Number 835616-60-9
EC Number 830-714-5
SMILES C1CC(=O)NC(=O)C1N2C(=O)C3=C(C2=O)C(=CC=C3)F
Properties
Solubility Very slightly soluble (0.47 g/L) (25 ºC), Calc.*
Density 1.570±0.06 g/cm3 (20 ºC 760 Torr), Calc.*
* Calculated using Advanced Chemistry Development (ACD/Labs) Software V11.02 (©1994-2019 ACD/Labs)
Safety Data
Hazard Symbols symbol symbol   GHS07;GHS08 Warning    Details
Hazard Statements H302-H312-H315-H319-H332-H335-H361    Details
Precautionary Statements P203-P261-P264-P264+P265-P270-P271-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P317-P318-P319-P321-P330-P332+P317-P337+P317-P362+P364-P403+P233-P405-P501    Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Skin irritationSkin Irrit.2H315
Eye irritationEye Irrit.2H319
Reproductive toxicityRepr.2H361
Acute toxicityAcute Tox.4H312
Acute toxicityAcute Tox.4H332
Specific target organ toxicity - single exposureSTOT SE3H335
SDS Available
up Discovory and Applicatios
The discovery of 2-(2,6-dioxopiperidin-3-yl)-4-fluoro-2,3-dihydro-1H-isoindole-1,3-dione stems from the study of biologically active piperidine and isoindole derivatives. Researchers have attempted to integrate fluorine atoms into the isoindole skeleton and dioxopiperidin moiety to create new compounds with enhanced therapeutic potential, hoping that it will provide better pharmacokinetic properties and biological efficacy.

The synthesis of this compound involves a multi-step process combining fluorination, cyclization, and condensation reactions. Common methods include: cyclization to form the isoindole ring structure; fluorination to introduce fluorine atoms at the 4-position of the isoindole ring; condensation to couple with the dioxopiperidinyl group. The process produces the target compound with the desired purity and structural integrity, which can be characterized by methods such as NMR, IR, and mass spectrometry. The product has a 4-fluoroisoindole core and a 2,6-dioxopiperidinyl group, usually in the form of a crystalline solid or powder, soluble in organic solvents and slightly soluble in water.

2-(2,6-dioxopiperidin-3-yl)-4-fluoro-2,3-dihydro-1H-isoindole-1,3-dione shows promise in pharmaceutical applications due to its structural features: it exhibits cytotoxic activity against certain cancer cell lines. The unique structure of the compound favors interaction with biological targets, potentially inhibiting the growth and proliferation of cancer cells. Studies have found that the compound has the ability to inhibit viral replication. The presence of fluorine atoms and the dioxopiperidin moiety enhances its interaction with viral enzymes, making it a candidate for antiviral drug development. Studies have shown that the compound has potential use as an anti-inflammatory agent, and its ability to modulate inflammatory pathways may allow it to treat inflammatory diseases.

In chemical research, the compound serves as a useful scaffold for the development of new derivatives and analogs. Its structure allows for modification, resulting in the synthesis of novel compounds with a variety of biological activities. Researchers use it to explore structure-activity relationships and optimize therapeutic properties.

The compound is valuable in medicinal chemistry as a lead compound for drug discovery. Its synthesis and subsequent testing provide insights into how modifications of the piperidine or isoindole rings affect biological activity. This understanding guides the design of new drugs with improved efficacy and safety.

As with many synthetic compounds, appropriate safety measures are necessary. Protective equipment such as gloves and goggles should be used when handling the compound to prevent contact. Proper storage in a cool, dry place is also essential to maintain its stability and prevent degradation.
Market Analysis Reports
List of Reports Available for 2-(2,6-Dioxopiperidin-3-yl)-4-fluoro-2,3-dihydro-1H-isoindole-1,3-dione
Related Products
N-(2,5-dioxooxolan-3-yl)acetamide  2,5-Dioxo-4-phenyl-4-imidazolidinepropionic acid  2,4-Dioxo-9-(phenylmethyl)-3,9-diazaspiro[5.5]undecane-1,5-dicarbonitrile  (2S-cis)-3,6-Dioxo-5-(phenylmethyl)-2-piperazineacetic acid monosodium salt  (4S)-delta,2-Dioxo-4-phenyl-3-oxazolidinepentanoic acid methyl ester  2-(3,6-Dioxo-5-phenyl-2-piperazinyl)-5,5-dimethyl-4-thiazolidinecarboxylic acid  (S)-3,6-Dioxo-2-piperazineacetic acid  (S)-2-(3,5-Dioxopiperazin-1-yl)propanoic acid  (-)-2,6-Dioxo-3-piperidinecarbamic acid benzyl ester  2-(2,6-Dioxopiperidin-3-yl)-5,6-difluoroisoindoline-1,3-dione  2-(2,6-Dioxopiperidin-3-yl)-5-fluoroisoindoline-1,3-dione  3,20-Dioxopregna-1,4,9(11),16-tetraen-21-yl acetate  3,20-Dioxopregn-4-en-17-beta-yl acetate  3,20-Dioxopregn-4-en-21-yl 4-bromobenzenesulfonate  Dioxopromethazine hydrochloride  N-[S-(1,2-Dioxopropyl)-N-L-gamma-glutamyl-L-cysteinyl]glycine  N-[3-(1,3-Dioxopropyl)phenyl]-N-ethylacetamide sodium  2,5-Dioxo-3-pyrrolidineacetic acid  2,5-Dioxo-3-pyrrolidinecarboxylic acid  1,3-Dioxo-2-isoindolineethanesulfonic acid